Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-06T14:10:11.235Z Has data issue: false hasContentIssue false

Pasteurized whole milk confers reduced susceptibilities to the antimicrobial agents trimethoprim, gatifloxacin, cefotaxime and tetracycline via the marRAB locus in Escherichia coli

Published online by Cambridge University Press:  07 November 2008

Yang Peng
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Ricardo L Hernandez
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Robert R Crow
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Suzanna E Jones
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Sara A Mathews
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Ayanna M Arnold
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Eliseo F Castillo
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Jennifer M Moseley
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
Manuel F Varela*
Affiliation:
Department of Biology, Eastern New Mexico University, Portales, New Mexico 88130USA
*
*For correspondence; e-mail: Manuel.Varela@enmu.edu
Rights & Permissions [Opens in a new window]

Abstract

We inoculated pasteurized whole milk with Escherichia coli strains GC4468 (intact marRAB locus), JHC1096 (Δ marRAB), or AG112 (Δ marR), and incubated each overnight at 37°C. All strains were then recovered from the milk cultures, and susceptibilities to antimicrobial agents were determined by the E-test strip method (CLSI). Cells of strain GC4468, prior to culturing in milk, were susceptible to trimethoprim, gatifloxacin, cefotaxime and tetracycline. After culturing GC4468 in pasteurized milk, however, the minimal inhibitory concentrations (MICs) increased 1·4-fold for trimethoprim (P⩽0·05), 1·5-fold for gatifloxacin (P⩽0·05), 2·0-fold for cefotaxime (P=0·008), and 1·4-fold for tetracycline (P⩾0·05). After culturing GC4468 on milk count agar the MICs were enhanced 3·4-fold for trimethoprim (P⩽0·05), 10-fold for gatifloxacin (P=0·001), 7·1-fold for cefotaxime (P=0·011), and 40·5-fold for tetracycline (P=0·074), but exhibiting tetracycline resistance with a mean MIC of 74·7±18·47 μg/ml (CLSI). The MICs of the antimicrobial agents for JHC1096 cells after culturing in pasteurized whole milk were indistinguishable (P⩾0·05) from baseline MICs measured before culturing in the same type of milk. Thus, Esch. coli cells harbouring the marRAB locus exhibit reduced susceptibilities to multiple antimicrobial agents after culturing in pasteurized whole milk.

Type
Research Article
Copyright
Copyright © Proprietors of Journal of Dairy Research 2008

Infectious diseases caused by bacteria that are resistant to antimicrobial agents are a serious public health concern (Neu, Reference Neu1992Barbosa & Levy, Reference Barbosa and Levy2000b; Levy & Marshall, Reference Levy and Marshall2004). Members of the Enterobacteriaceae family of bacteria are causative agents of infectious disease, and their resistance to antimicrobial agents compromises chemotherapeutic efforts (Paterson, Reference Paterson2002). Antimicrobial agents are used in agriculture for the treatment of infection, prophylaxis and growth promotion (Levy, Reference Levy2002; Levy & Marshall, Reference Levy and Marshall2004).

Bacterial resistance to antimicrobial agents may be of clinical significance due to dissemination of pathogenic bacteria through a population of food animals (McDermott et al. Reference McDermott, Zhao, Wagner, Simjee, Walker and White2002; Angulo et al. Reference Angulo, Baker, Olsen, Anderson and Barrett2004; Silbergeld et al. Reference Silbergeld, Graham and Price2008). In isolated instances, outbreaks of food-borne infectious disease from contaminated milk and occurrences of milk-derived isolates of members from the Enterobacteriaceae family of bacteria have been studied (Gillespie et al. Reference Gillespie, Adak, O'Brien and Bolton2003). Although relatively well-studied within dairy cattle (Hershberger et al. Reference Hershberger, Oprea, Donabedian, Perri, Bozigar, Bartlett and Zervos2005), bacteria that are resistant to antimicrobial agents in other dairy farm environments, such as soil (Burgos et al. Reference Burgos, Ellington and Varela2005), water (Biyela et al. Reference Biyela, Lin and Bezuidenhout2004) and milk (Makovec & Ruegg, Reference Makovec and Ruegg2003) are less well-characterized. Dissemination mechanisms for drug resistant bacterial pathogens within dairy farms are also poorly understood (Hershberger et al. Reference Hershberger, Oprea, Donabedian, Perri, Bozigar, Bartlett and Zervos2005).

The marRAB locus is a well studied genetic element in Escherichia coli and mediates bacterial resistance to multiple antimicrobial agents such as β-lactams, chloramphenicol, quinolones, and tetracycline (Randall & Woodward, Reference Randall and Woodward2002). Several organic compounds are known to modulate resistance to antimicrobial agents via the marRAB locus (Alekshun & Levy, Reference Alekshun and Levy1999). Previously, milk-containing foods were shown to modulate the marRAB locus (Rickard et al. Reference Rickard, Lindsay, Lockwood and Gilbert2004); the effects of milk, however, were not directly examined. Thus, we tested the hypothesis that milk confers reduced susceptibilities to antimicrobial agents in Esch. coli cells harboring the marRAB locus. The objective of this study was to examine the relationship between the culturing of Esch. coli in milk and the subsequent development of resistance to antimicrobial agents. Here, we found that upon culturing in pasteurized milk, antimicrobial agent-sensitive Esch. coli becomes less susceptible to multiple antimicrobial agents, a phenotype conferred by the marRAB locus.

Materials and Methods

Bacterial strains

Esch. coli K-12 bearing a deletion of the marRAB operon (strain JHC1096), was a generous gift from Dr. Jean Greenberg (Harvard University, MA; Greenberg et al. Reference Greenberg, Chou, Monach and Demple1991). The Esch. coli strain harbouring a deletion of marR (strain AG112) (George & Levy, Reference George and Levy1983; Moken et al. Reference Moken, McMurry and Levy1997), and a wild-type strain harbouring an intact marRAB locus (strain GC4468) (Carlioz & Touati, Reference Carlioz and Touati1986; Oethinger et al. Reference Oethinger, Podglajen, Kern and Levy1998) were generous gifts from the laboratory of Dr. Stuart Levy (Tufts University, MA).

Growth determination in Luria-Bertani broth and milk

Cells JHC1096, AG112, and GC4468 were grown overnight at 37°C while shaking in Luria-Bertani (LB) broth (Difco), which is routinely used for maintenance and propagation of Esch. coli (Luria et al. Reference Luria, Adams and Ting1960). Then 20 μl of culture was added to 20 ml fresh LB broth and grown to the mid-log phase of growth (O.D.600=0·35). Next, 10 μl of the mid-log culture was used to inoculate 10 ml of fresh LB broth or commercially available pasteurized whole milk. This procedure was repeated as above except that the LB broth and the pasteurized whole milk each contained 5 mm-Salicylate. The cultures were incubated while shaking at 37°C for the times indicated in Figs. 1 & 2. Samples (10 μl) of the cultures were removed at the time points indicated, plated onto MacConkey agar, and incubated for 12 h. Colony forming units (CFU/ml) were then determined. The means plotted were the results of 4 independent experiments, each in triplicate.

Fig. 1. Effects of salicylate on bacterial growth (CFU) in LB broth.

Esh. coli cells of strains AG112 (filled circles), JHC1096 (empty circles) and GC4468 (filled triangles) were incubated in LB broth without inducer (i.e., no salicylate), panel A, or in LB broth with inducer (5 mm-salicylate), panel B. See methods for details

Fig. 2. Effects of salicylate on bacterial growth (CFU) in milk.

Esch. coli cells of strains AG112 (filled circles), JHC1096 (empty circles) and GC4468 (filled triangles) were incubated in pasteurized milk without inducer (i.e., no salicylate), panel A, or in pasteurized milk containing inducer (5 mm-salicylate), panel B. See methods for details

Antimicrobial susceptibility testing

Prior to antimicrobial susceptibility testing via the E-Test assay using current CLSI guidelines (2006), Esch. coli cells JHC1096, AG112, and GC4468 were treated with LB broth (Difco) with and without 5 mm-salicylate, commercially available pasteurized whole milk, or milk count agar (OXIOD) in the following manner: Esch. coli strains JHC1096, AG112 and GC4468 were inoculated in LB Broth (Difco), incubated overnight at 37°C with aeration and then used to inoculate refresher cultures in LB broth (Difco) for growth to the mid-log phase (O.D.600≈0·35). The mid-log cells were used for incubation in LB broth (Difco) (with and without 5 mm-salicylate) at 37°C with aeration for 8 h or for incubation in commercially available pasteurized whole milk at 30°C with aeration for 8 h. An additional 10 ml pasteurized whole milk was inoculated with 10 μl sterile distilled water as a negative control. For the treatment in LB broth (Difco) with or without 5 mm-salicylate, a total of 50 μl of each culture was plated onto LB agar medium (Difco) plates and incubated overnight at 37°C. For the treatment in pasteurized whole milk, a total of 50 μl of each culture was plated onto either LB agar (Difco) or milk count agar (OXIOD) and incubated at 30°C for 24 h.

For the antimicrobial agent susceptibility measurements, three single colonies of each strain were randomly picked from each of the plates, resuspended in 1 ml per colony of 0·85% NaCl and each immediately spread uniformly onto cation-adjusted Muller-Hinton II Agar (Difco) plates or Milk Count Agar. A portion of the 0·85% NaCl resuspension (0·1 ml) was plated onto LB agar, and cells were identified by BD BBL Crystal Enteric/Nonfermentor Identification Kits (Becton Dickinson Microbiology Systems, Cockeysville, MD) according to the manufacturer specifications. E-Test strips (AB Biodisk) were placed on the surface as per the manufacturer's instructions, and the plates were incubated at 37°C for 16 h. The minimal inhibitory concentrations (MICs) were read and interpreted according to current CLSI guidelines (2006). The means±sd (ranges) were the result of three independent experiments, each in triplicate, n=3. Break points for susceptibility interpretations were MICs ⩽8 μg/ml for trimethoprim, ⩽2 μg/ml for gatifloxacin, ⩽8 μg/ml for cefotaxime, and ⩽4 μg/ml for tetracycline. The MIC break point for resistance to tetracycline was ⩾16 μg/ml.

Statistics

All data represent the mean plus or minus the standard deviation and range of at least three independent experiments (n=3) conducted under standardized conditions. The nonparametric Holm-Sidak method was used to determine the significance of mean MIC data compared with mean baseline MICs within each strain. Results were considered significant at P⩽0·05.

Results and Discussion

Baseline determinations of antimicrobial susceptibilities

Prior to culturing Esch. coli strains GC4468 (intact marRAB locus), JHC1096 (marRAB deleted) AG112 (marR deleted) in pasteurized whole milk or milk count agar, the minimal inhibitory concentrations (MICs) were determined by the standard E-test method (2006). All three Esch. coli strains were susceptible to the antimicrobial agents trimethoprim, gatifloxacin, cefotaxime and tetracycline (Table 1). These antimicrobial agents represent distinct drug classes and have different mechanisms of actions (McDermott et al. Reference McDermott, Walker and White2003). These agents also have significance in clinical therapy, such as trimethoprim (Juckett, Reference Juckett1999; Casewell et al. Reference Casewell, Friis, Marco, McMullin and Phillips2003), gatifloxacin (Lutsar et al. Reference Lutsar, Friedland, Jafri, Wubbel, Ng, Ghaffar and McCracken Jr1999), and cefotaxime (Wittmann et al. Reference Wittmann, Jones, Malledant and Privitera1997) or significance in agriculture for the purposes of growth promotion or prophylaxis in dairy calves, such as tetracycline (Constable & Morin, Reference Constable and Morin2002).

Table 1. Minimal inhibitory concentrations of antimicrobial agents for Esch. coli in pasteurized milk, milk count agar or salicylate

MIC values (CLSI) are presented as the mean±sd (range), n=3. See methods for details

* P⩽0·05, **P⩽0·01 and ***P⩽0·001 compared to baseline MICs for the same Esch. coli strain

Antimicrobial susceptibilities after culturing in pasteurized milk and milk count agar

We found that after culturing Esch. coli GC4468 (intact marRAB locus) in pasteurized milk, the antimicrobial agent MICs increased by 1·4-fold for trimethoprim (P=0·05), by 1·5-fold for gatifloxacin (P⩽0·05), and by 2·0-fold for cefotaxime (P=0·008), as shown in Table 1. The 1·4-fold increase in mean MIC for tetracycline was not significantly different in GC4468 (P⩾0·05). The mean MIC in AG112 (marR deleted) increased (P=0·003) by 2·8-fold for trimethoprim, but not for gatifloxacin, cefotaxime, and tetracycline (P=0·10). The MICs for the same antimicrobial agents in Esch. coli AG112 were not significantly different (P⩾0·05) compared with the MIC values obtained prior to culturing in milk and milk count agar, implying that the marRAB locus in AG112 was already intrinsically induced, as expected, and that another inducer (milk) would not further modulate susceptibility. The MICs of the antimicrobial agents tested in this study (ranged between 0·01 and 0·017 μg/ml) for cells of JHC1096 (marRAB locus deleted) after culturing in pasteurized whole milk were indistinguishable (P⩾0·05) from the MICs determined prior to culturing (Table 1) in the same type of milk.

As shown in Table 1, we found that after culturing Esch. coli GC4468 on milk count agar, the antimicrobial agent MICs increased by 3·4-fold for trimethoprim (P=0·036), by 10-fold for gatifloxacin (P=0·001), by 7·1-fold for cefotaxime (P=0·011), and by 40·5-fold for tetracycline (P=0·074) compared with the mean MICs derived prior to culturing on milk count agar. Interestingly, GC4468 cells on milk count agar with a mean MIC 74·67 μg/ml are considered resistant to tetracycline, if not susceptible. As expected, cells of AG112 (marR deleted) were not less susceptible to the antimicrobial agents tested compared with baseline MICs (P⩾0·05), regardless of whether milk or milk count agar was used, further implying that within induced cells, susceptibilities are not further reduced. For instance, AG112 cells were considered tetracycline resistant regardless of the variable tested (Table 1), as would be expected if the marRAB locus was induced. The MICs of the antimicrobial agents for JHC1096 cells (ranging between 0·01–0·017 μg/ml) after culturing in pasteurized whole milk or milk count agar were indistinguishable (P⩾0·05) from the MICs determined prior to culturing (Table 1) in the same milk-type, except for an observed 5-fold increase in the MIC of gatifloxacin (P<0·05) for JHC1096 cultured on milk count agar (but not pasteurized milk) compared with the baseline MIC in gatifloxacin. Prior to culturing in milk or milk agar, Esch. coli strains GC4468 and JHC1096 were susceptible to all antimicrobial agents tested. The reductions in antimicrobial agent susceptibilities in milk were more pronounced in GC4468 after sub-culturing on milk count agar compared with sub-culturing in pasteurized milk. We conclude that culturing in pasteurized milk or milk agar, Esch. coli cells harboring an intact marRAB locus become less susceptible to multiple antimicrobial agents.

Measurement of antimicrobial susceptibilities with salicylate

As a positive control experiment for the induction of the marRAB locus, the antimicrobial agent MICs were determined in 5 mm-salicylic acid, a well-known marRAB locus inducer (Alekshun & Levy, Reference Alekshun and Levy1999). As shown in Table 1, in the presence of salicylate, the MICs increased for trimethoprim (P=0·01) and cefotaxime (P=0·008) in GC4468 cells. AG112 cells (marR deleted) with or without salicylate had tetracycline MICs of 213 and 256 μg/ml, respectively, while JHC1096 cells (marRAB locus deleted) remained susceptible to tetracycline and the other antimicrobial agents tested, consistent with the known marRAB locus resistance properties (Alekshun & Levy, Reference Alekshun and Levy1999).

The observation that the antimicrobial agent susceptibilities were unchanged in the Esch. coli strain that lacks MarR and which constitutively expresses MarA, a multiple antibiotic resistance activator (Hachler et al. Reference Hachler, Cohen and Levy1991; Barbosa & Levy, Reference Barbosa and Levy2000a), confirms the role of the marRAB locus in conferring reduced susceptibilities to antimicrobial agents by milk in GC468 cells, which possess an intact marRAB locus. The component within milk that modulates the marRAB locus remains to be identified. Although chromosomal elements are directly involved in the reduced antimicrobial susceptibilities observed here, we are nonetheless not able to definitively rule out the possibility that extra-chromosomal elements (i.e., plasmids, etc.) may be involved in naturally-derived environmental or agriculture bacterial isolates (Burgos et al. Reference Burgos, Ellington and Varela2005). Future studies are necessary to distinguish between these alternatives. Along these lines, we are presently examining the antimicrobial agent susceptibility profiles for previously published Esch. coli isolates from dairy soil (Burgos et al. Reference Burgos, Ellington and Varela2005) and from dairy water for a new panel of antimicrobial agents.

Growth in LB medium and milk

The growth of Esch. coli strain AG112 cells reached higher growth plateaus when compared with those of GC4468 and JHC1096 strains in both LB broth and in milk (see Figs 1 & 2). All three strains, however, reach higher growth plateaux in LB broth than in milk. Our investigation of the relationship of Esch. coli growth indicates that the total growth yield in LB broth is better than that in liquid milk while the antimicrobial agent susceptibilities are reduced, which is consistent with the contention that milk itself, and not growth in milk, is the factor conferring the reduced susceptibilities that we observe here.

In summary, pasteurized milk or milk agar media confers reduced susceptibilities to multiple antimicrobial agents in Esch. coli. Our studies provide evidence to support the contention that the mode of acquisition of reduced susceptibilities to antimicrobial agents by Esch. coli in pasteurized milk is due to modulation of the marRAB locus. We examined Esch. coli, which is a model bacterium and member of the Enterobacteriaceae family of bacteria, because of its relevance to physiology, its biomedical role as a causative agent of infectious disease and its antimicrobial agent resistance properties, which in turn compromise therapy (Sanders & Sanders, Reference Sanders and Sanders Jr1992; Baquero et al. Reference Baquero, Negri, Morosini and Blazquez1998; Alekshun & Levy, Reference Alekshun and Levy2006). Esch. coli microorganisms have profound significance as a tool for molecular biology, microbial genetics, and as indicators of environmental sewage contamination, plus pathogenic Esch. coli variants have considerable clinical importance (Neidhardt, Reference Neidhardt1996). Because of their demonstrated transferability of antimicrobial agent resistance determinants among bacteria of distinct species (Neu, Reference Neu1984; Nord, Reference Nord1993; Leverstein-van Hall et al. Reference Leverstein-van Hall, Blok, Donders, Paauw, Fluit and Verhoef2003), human consumption of raw milk contaminated with multidrug resistant microorganisms may contribute to the dissemination of multidrug resistant bacteria in agriculture and could be a source of potentially untreatable zoonotic infectious disease (Tollefson et al. Reference Tollefson, Fedorka-Cray and Angulo1999; McEwen & Fedorka-Cray, Reference McEwen and Fedorka-Cray2002; Angulo et al. Reference Angulo, Baker, Olsen, Anderson and Barrett2004). Lastly, because the marRAB locus is present in other members of the Enterobacteriaceae family of bacteria, such as Enterobacter, Klebsiella, Shigella, and Salmonella (Cohen et al. Reference Cohen, Yan and Levy1993), the findings presented here have relevance to these medically important microorganisms and their relationships with milk.

This publication was made possible by National Institutes of Health grants 1 R15 GM070562-01 and P20 RR016480, the latter of which is from the NM-INBRE program of the National Center for Research Resources, an internal research grant awarded by Eastern New Mexico University, and a contribution from Calton Research Associates in honor of George and Clytie Calton. E.F.C. was supported by NIH grants RR-16480, R25-GM56626 Bridges fellowship and by NSF grants NM-AGEP and HRD-0086701. R.R.C. was supported by an American Society for Microbiology Undergraduate Research Fellowship. We thank Dr. Sanath Kumar, Jamey F. Licata and Johnny Sena for expert technical assistance. We thank Dr. Jeffrey K. Griffith (University of New Mexico, Albuquerque, NM) and Dr. Tomofusa Tsuchiya (Okayama University, Okayama, Japan) for critical reading of the manuscript before publication.

References

Alekshun, MN & Levy, SB 1999 Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. Journal of Bacteriology 181(15) 46694672.CrossRefGoogle ScholarPubMed
Alekshun, MN & Levy, SB 2006 Commensals upon us. Biochemical Pharmacology 71(7) 893900CrossRefGoogle ScholarPubMed
Angulo, FJ, Baker, NL, Olsen, SJ, Anderson, A & Barrett, TJ 2004 Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans. Seminars in Pediatric Infectious Diseases 15(2) 7885CrossRefGoogle ScholarPubMed
Baquero, F, Negri, MC, Morosini, MI & Blazquez, J 1998 Antibiotic-selective environments. Clinical Infectious Diseases 27 (Suppl. 1) S511CrossRefGoogle ScholarPubMed
Barbosa, TM & Levy, SB 2000a Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. Journal of Bacteriology 182(12) 34673474CrossRefGoogle ScholarPubMed
Barbosa, TM & Levy, SB 2000b The impact of antibiotic use on resistance development and persistence. Drug Resistance Update 3(5) 303311CrossRefGoogle ScholarPubMed
Biyela, PT, Lin, J & Bezuidenhout, CC 2004 The role of aquatic ecosystems as reservoirs of antibiotic resistant bacteria and antibiotic resistance genes. Water Science Technology 50(1) 4550CrossRefGoogle ScholarPubMed
Burgos, JM, Ellington, BA & Varela, MF 2005 Presence of multidrug-resistant enteric bacteria in dairy farm topsoil. Journal of Dairy Science 88(4) 13911398CrossRefGoogle ScholarPubMed
Carlioz, A & Touati, D 1986 Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO Journal 5(3) 623630CrossRefGoogle ScholarPubMed
Casewell, M, Friis, C, Marco, E, McMullin, P & Phillips, I 2003 The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. Journal of Antimicrobial Chemotherapy 52(2) 159161CrossRefGoogle ScholarPubMed
Clinical and Laboratory Standards Institute 2006 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard – Seventh Edition (M7-A7). Wayne PAGoogle Scholar
Cohen, SP, Yan, W & Levy, SB 1993 A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. Journal of Infectious Diseases 168(2) 484488CrossRefGoogle ScholarPubMed
Constable, PD & Morin, DE 2002 Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. Journal of the American Veterinary Medical Association 221(1) 103108CrossRefGoogle ScholarPubMed
George, AM & Levy, SB 1983 Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. Journal of Bacteriology 155(2) 531540CrossRefGoogle ScholarPubMed
Gillespie, IA, Adak, GK, O'Brien, SJ & Bolton, FJ 2003 Milkborne general outbreaks of infectious intestinal disease, England and Wales, 1992–2000. Epidemiology and Infection 130(3) 461468CrossRefGoogle ScholarPubMed
Greenberg, JT, Chou, JH, Monach, PA & Demple, B 1991 Activation of oxidative stress genes by mutations at the soxQ/cfxB/marA locus of Escherichia coli. Journal of Bacteriology 173(14) 44334439CrossRefGoogle ScholarPubMed
Hachler, H, Cohen, SP & Levy, SB 1991 marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology 173(17) 55325538CrossRefGoogle Scholar
Hershberger, E, Oprea, SF, Donabedian, SM, Perri, M, Bozigar, P, Bartlett, P & Zervos, MJ 2005 Epidemiology of antimicrobial resistance in enterococci of animal origin. Journal of Antimicrobial Chemotherapy 55(1) 127130CrossRefGoogle ScholarPubMed
Juckett, G 1999 Prevention and treatment of traveler's diarrhea. American Family Physician 60(1) 119124, 135136Google ScholarPubMed
Leverstein-van Hall, MA, Blok, HEM, Donders, ART, Paauw, A, Fluit, AC & Verhoef, J 2003 Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. Journal of Infectious Diseases 187(2) 251259CrossRefGoogle ScholarPubMed
Levy, SB 2002 The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. Journal of Antimicrobial Chemotherapy 49(1) 2530CrossRefGoogle ScholarPubMed
Levy, SB & Marshall, B 2004 Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine 10 (Suppl. 12) S122129CrossRefGoogle ScholarPubMed
Luria, SE, Adams, JN & Ting, RC 1960 Transduction of lactose-utilizing ability among strains of E. coli and S. dysenteriae and the properties of the transducing phage particles. Virology 12 348390CrossRefGoogle ScholarPubMed
Lutsar, I, Friedland, IR, Jafri, HS, Wubbel, L, Ng, W, Ghaffar, F & McCracken Jr, GH 1999 Efficacy of Gatifloxacin in Experimental Escherichia coli Meningitis. Antimicrobial Agents and Chemotherapy 43(7) 18051807CrossRefGoogle ScholarPubMed
Makovec, JA & Ruegg, PL 2003 Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994–2001). Journal of the American Veterinary Medical Association 222(11) 15821589CrossRefGoogle Scholar
McDermott, PF, Walker, RD & White, DG 2003 Antimicrobials: modes of action and mechanisms of resistance. International Journal of Toxicology 22(2) 135143CrossRefGoogle ScholarPubMed
McDermott, PF, Zhao, S, Wagner, DD, Simjee, S, Walker, RD & White, DG 2002 The food safety perspective of antibiotic resistance. Animal Biotechnology 13(1) 7184CrossRefGoogle ScholarPubMed
McEwen, SA & Fedorka-Cray, PJ 2002 Antimicrobial use and resistance in animals. Clinical Infectious Diseases 34 (Suppl. 3) S93S106CrossRefGoogle ScholarPubMed
Moken, MC, McMurry, LM & Levy, SB 1997 Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents and Chemotherapy 41(12) 27702772CrossRefGoogle ScholarPubMed
Neidhardt, FC 1996 Escherichia coli and Salmonella: Cellular and Molecular Biology. Washington, D.C.: ASM PressGoogle Scholar
Neu, HC 1984 Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection. American Journal of Medicine 76(5A) 1127CrossRefGoogle ScholarPubMed
Neu, HC 1992 The crisis in antibiotic resistance. Science 257(5073) 10641073CrossRefGoogle ScholarPubMed
Nord, CE 1993 The effect of antimicrobial agents on the ecology of the human intestinal microflora. Veterinary Microbiology 35(3–4) 193197CrossRefGoogle ScholarPubMed
Oethinger, M, Podglajen, I, Kern, WV & Levy, SB 1998 Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrobial Agents and Chemotherapy 42(8) 20892094CrossRefGoogle ScholarPubMed
Paterson, DL 2002 Serious infections caused by enteric gram-negative bacilli–mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patient. Seminars in Respiratory Infections 17(4) 260264CrossRefGoogle ScholarPubMed
Randall, LP & Woodward, MJ 2002 The multiple antibiotic resistance (mar) locus and its significance. Research in Veterinary Science 72(2) 8793CrossRefGoogle ScholarPubMed
Rickard, AH, Lindsay, S, Lockwood, GB & Gilbert, P 2004 Induction of the mar operon by miscellaneous groceries. Journal of Applied Microbiology 97(5) 10631068CrossRefGoogle ScholarPubMed
Sanders, CC & Sanders Jr, WE 1992 beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clinical Infectious Diseases 15(5) 824839CrossRefGoogle ScholarPubMed
Silbergeld, EK, Graham, J & Price, LB 2008 Industrial food animal production, antimicrobial resistance, and human health. Annual Review of Public Health 29 151169CrossRefGoogle ScholarPubMed
Tollefson, L, Fedorka-Cray, PJ & Angulo, FJ 1999 Public health aspects of antibiotic resistance monitoring in the USA. Acta Veterinaria Scandinavica (Suppl.) 92 6775Google ScholarPubMed
Wittmann, D, Jones, R, Malledant, J & Privitera, G 1997 Cefotaxime in the treatment of prophylaxis of surgical infections. Journal of Chemotherapy 9 (Suppl. 2) 1933Google ScholarPubMed
Figure 0

Fig. 1. Effects of salicylate on bacterial growth (CFU) in LB broth.Esh. coli cells of strains AG112 (filled circles), JHC1096 (empty circles) and GC4468 (filled triangles) were incubated in LB broth without inducer (i.e., no salicylate), panel A, or in LB broth with inducer (5 mm-salicylate), panel B. See methods for details

Figure 1

Fig. 2. Effects of salicylate on bacterial growth (CFU) in milk.Esch. coli cells of strains AG112 (filled circles), JHC1096 (empty circles) and GC4468 (filled triangles) were incubated in pasteurized milk without inducer (i.e., no salicylate), panel A, or in pasteurized milk containing inducer (5 mm-salicylate), panel B. See methods for details

Figure 2

Table 1. Minimal inhibitory concentrations of antimicrobial agents for Esch. coli in pasteurized milk, milk count agar or salicylateMIC values (CLSI) are presented as the mean±sd (range), n=3. See methods for details